Albemarle holds the cleaner structural position, with the lead spread across valuation and growth. Sartorius Stedim Biotech does not offset that deficit through any equally strong structural edge elsewhere. On the market side, Albemarle is in better shape — its trend is intact while Sartorius Stedim Biotech's trend has broken down. That puts structure and market broadly in agreement — Albemarle's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (ALB: S&P 500, DIM.PA: STOXX 600).
The result is anchored in valuation, but growth also reinforces the same direction. The overall score gap is 21 points in favour of Albemarle Corporation.
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
The pair shares a valid long-term profile match, but the trajectories are not especially close.
The match is driven mainly by revenue growth trajectory and investment intensity.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
The two profiles are relatively close, but the price setup still leans toward Albemarle Corporation.
Valuation position uses Forward P/E and peer-relative PE percentile (idx_pct_pe) where available.
Where ALB and DIM.PA each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The multiple-based pricing edge comes from a forward P/E that is 9.8 turns lower.
Capital efficiency also runs the other way, with a 11.1-point ROIC edge acting as a real counterforce.
The lead is built on both valuation and growth, making it broader than a single-dimension result.
Break down the ALB vs DIM.PA comparison across all dimensions with the full interactive tool.
Explore how ALB and DIM.PA each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.